Aeolus Pharmaceuticals Inc (OTC:AOLS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Russell Skibsted Other companies: Processa Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Jul 16, 2024); Alimera Sciences Inc (Chief Financial Officer & SVP · Jan 9, 2023 – Nov 21, 2023 · Past); Rockwell Medical, Inc. (See Remarks · Sep 15, 2020 – Sep 9, 2022 · Past); Serina Therapeutics, Inc. (Chief Financial Officer · Nov 27, 2018 – Dec 31, 2018 · Past); Insight Molecular Diagnostics Inc. (Chief Financial Officer · Dec 30, 2015 – Dec 30, 2015 · Past); Lineage Cell Therapeutics, Inc. (Chief Financial Officer · Nov 16, 2015 – Dec 18, 2018 · Past) | Chief Financial Officer · Since at least May 23, 2012 |
| Chris A. Rallis Other companies: Fennec Pharmaceuticals Inc. (Director · Since at least Sep 11, 2017); Tenax Therapeutics, Inc. (Director · Dec 16, 2011 – Jun 15, 2020 · Past) | Board Member · Since at least Sep 12, 2006 |
| Amit Kumar Other companies: Anixa Biosciences, Inc. (Chief Executive Officer, Director · Since at least May 8, 2018) | Board Member · Since at least Nov 14, 2026 |
| David C. Cavalier Other companies: Anixa Biosciences, Inc. (Director · Sep 27, 2018 – Aug 13, 2020 · Past) | Chairman · Since at least Jul 27, 2007 |
| Joseph J Krivulka Other companies: Nektar Therapeutics (Director · Sep 19, 2013 – Sep 19, 2017 · Past) | Director · May 8, 2013 – May 8, 2013 · Past |
| Brian Day | Chief Scientific Officer · Since at least Nov 14, 2026 |
| Christopher Stanley | VP, Operations · Since at least Nov 14, 2026 |
| Jeffrey A. Scott | Board Member · Since at least Nov 14, 2026 |
| John L. McManus | Chief Executive Officer · Since at least Dec 30, 2005 |
| John M. Clerici | Board Member · Since at least Nov 14, 2026 |
| John M. Farah | Board Member · Since at least Nov 14, 2026 |
| Mitchell D. Kaye | Board Member · Since at least Nov 14, 2026 |